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One sentence summary: The authors report on a new adhesin, that they have named coli surface antigen 8 subtype B (CS8B); to date, there are five
variants of CS8 undetectable using current primers.
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ABSTRACT
Enterotoxigenic Escherichia coli (ETEC) strains harbor multiple fimbriae and pili to mediate host colonization, including the
type IVb pilus, colonization factor antigen III (CFA/III). Not all colonization factors are well characterized or known in toxin
positive ETEC isolates, which may have an impact identifying ETEC isolates based on molecular screening of these
biomarkers. We describe a novel coli surface antigen (CS) 8 subtype B (CS8B), a family of CFA/III pilus, in a toxin producing
ETEC isolate from a Kenyan collection. In highlighting the existence of this putative CS, we provide the sequence and
specific primers, which can be used alongside other ETEC primers previously described.
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Enterotoxigenic Escherichia coli (ETEC) pathotypes are a ma-
jor cause of infantile watery diarrhea in developing countries as
well as in travellers globally (Qadri et al. 2005). They are defined
by the presence of a heat-labile toxin and/or a heat-stable toxin
(Nataro and Kaper 1998). In addition, ETEC is known to carry an
array of colonization factor antigens (CFAs) or adhesive fimbriae
that promote adherence to and colonization of the host intesti-
nal epithelial cells thus playing an important role in disease in-
stigation and pathogenesis (Turner et al. 2006).
To date, 20 distinct colonization factors (CFs) have been iden-
tified in ETECs causing diarrhea in humans namely CFAI, CS1–8
and CS12–23 (Rodas et al. 2009; Mazariego-espinosa et al. 2010).
ETECs may express one of two-type IVb pilli, CFA/III of coli sur-
face antigen 8 (CS8) or Longus of coli surface antigen 21 (CS21).
The CFA/III consists of a cluster of 14 member genes that make
up the cof operon (Taniguchi et al. 2001; Yuen et al. 2013).
We describe a novel type IVb, CFA/III colonization factor des-
ignated CS8B, carried by an ETEC strain ESEI 111 obtained in
September 2013 from a child under 5 years of age presenting
with watery diarrhea. Escherichia coli strain ESEI 111 was se-
quenced at theWellcome Trust Sanger Institute as part of a pilot
global ETEC project. Genomic DNA was isolated by QIAamp R©
DNA mini Kit (Eigen, Courtaboeuf, France) and sequenced us-
ing the Illumina HiSeq2000 platform. Paired-end reads of 100
bp were assembled using Velvet (Zerbino 2011). For future
epidemiological screening, primers for selected genes: cofJ-B
and cofP-B of CS8B were designed using SeqBuilder software
(Table 1) and were tested on the ESEI 111 strain. All the PCR
Received: 6 March 2015; Accepted: 10 July 2015
C© FEMS 2015. This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided
the original work is properly cited.
1
2 FEMS Pathogens and Disease, 2015, Vol. 73, No. 7
Table 1. Primers designed for CS8B.
Primer name 5′ -3′ Sequence Annealing Tm Product size
CS8-JB F GCCGGGGATGGCATCACCA 64 968 bp
CS8-JB R GCGTTTATAAGAGGCTATCTG 60
CS8-PB F CACTGGTATGTGTGTTGGTAGC 64 730 bp
CS8-PB R GGAAATTGCCGGGCCAAAAG 62
Figure 1. Comparative genomics for CS8 and CS8B from this study. Comparative genomics with CS8B cof operon from this study at the bottom and CS8 of accession
AB049751 at the top using GenomeMatcher (Ohtsubo et al. 2008). cofR, cofS, cofT, cofB, cofC, cofD, cofE, cofF, cofG, cofH and cofI remain conserved with more than 96%
similarity upstream. CFA/III gene products are cofA- major pilin, cofB- minor pilin, cofD- secretin, cofE, cofF and cofG- IMAPs (inner membrane accessory proteins),
cofH- assembly ATPase, cofI- IMCP (inner membrane core protein), cofJ- secreted colonization factor, cofP- prepilin peptidase. Comparing CS8B cof operon to CS8 reveals
divergence in cofA, cofP and cofJ, which encode the major subunit pilin, the prepilin peptidase and the secreted colonization factor, respectively. Colored scale on the
right-hand side indicates percent nucleotide identity. Off-white areas between cofA, cofJ and cofP represent regions of no synteny.
reactions (single or multiplex) were performed in 25 μl final vol-
ume containing 1 μl of the template DNA, 22 μl of water and
0.5 μl of each primermixedwith the Ready-To- Go PCR Beads (GE
healthcare, Buckinghamshire, UK) according to manufacturer’s
specifications. The thermocycling conditions were as follows:
95◦C for 2 min, 95◦C for 30 s, 60◦C for 30 s and 30 s at 72◦C for 35
cycles, with a final 10 min extension at 72◦C, and the PCRs were
performed in the DNA Engine PTC-0221 Dyad Cycler. Multilocus
sequence typing (MLST) was performed as previously described
(Aanensen and Spratt 2005). Plasmid typing was carried out in
silico using an in-house script and primer sequences described
previously (Carattoli et al. 2005). Manual annotation was carried
out using the genome viewer Artemis (Rutherford et al. 2000).
Comparative genomics of CS8B to available complete CS8 operon
coding sequences from European Nucleotide Archive (ENA) was
performed using GenomeMatcher (Ohtsubo et al. 2008). To de-
termine the phylogenetic relationship between nucleotide se-
quences of 33 cofJ, 17 lngJ and one tcpJ, a tree was inferred by
using the maximum likelihood method based on the Tamura–
Nei model using the poisson model of amino acid substitution,
uniform rates among sites, with a 95% site coverage cut-off and
1000 bootstrap replicates (Tamura and Nei 1993). Percentage nu-
cleotide identities were calculated using ClustalW Omega (Siev-
ers et al. 2011). The KEMRI/National Ethics Review Committee
SCC No 2507 approved all procedures.
ESEI 111, by MLST, belongs to sequence type 410, encodes a
heat labile toxin (eltA and eltB) and harbors amultidrug-resistant
IncI1 plasmid encoding tetB, blaTEM-1, sul2, strA, ampC and dfrA8
resistance genes.
Although our understanding of the pathogenesis of ETEC has
been accelerated by data fromwhole genome sequencing (WGS),
not all CFs have been identified. Current moelcular screening of
ETECs involves PCR amplification of the known toxin genes and
CFs (Rodas et al. 2009). However, some ETECs are classed as CF
negative either because they lack a CF or they may harbor un-
known or divergent CFs. ESEI 111 is one such isolate lacking all
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Figure 2. Phylogeny of CS8, CS8B from this study and CS21. Phylogenetic dendrogram constructed by themaximum likelihoodmethod based on the Tamura–Nei model
with MEGA 6.05, based on the complete major subunits of Type 4b pili gene sequences of cofJ, tcpJ and lngJ obtained from ENA. cofJ of CS8B from this study is shown in
red. Most of the isolates originate from Bangladesh and those from other regions and their respective clusters are also indicated.
known CFs, as defined by PCR, but haboring a CS8B operon.WGS
of ESEI 111, followed by mapping of the resultant short reads to
all known CFs using SMALT software version 0.6.4 and a 90%
identity cut-off, showed that this isolate did in fact harbor a
CF which was related, but distinct from the well-characterized
CF CS8 operon. Figure 1 shows the comparative genomic anal-
ysis of cofR, cofS, cofT, cofA-J and cofP which are predicted to en-
code the CS8B CF protein with the orthologous cluster encoding
CS8 (Taniguchi et al. 2001). These data showed that CS8B was a
chimeric operon with cofR, cofS, cofT, cofB, cofC, cofD, cofE, cofF,
cofG, cofH and cofI showing more than 96% sequence identity to
their orthologs in the CS8 operon. However, cofA, cofJ and cofP,
which encode the major subunit pilin, the secreted CF and the
prepilin peptidase, respectively, were highly divergent showing
less than 88% identity with their CS8 orthologs.
Phylogenetic analysis of all known prepilin peptidases re-
lated to cofJ showed that CS8B, clusters distinctly from all other
cofJ genes (Fig. 2), and homolog tcpJ of Vibrio cholerae (EAZ73994),
which has 44% identity to the CS8B cofJ gene identified in this
study. We observed three distinct clusters of variant cofJ genes:
Cluster I (1065 bp), Cluster II (1074 bp), III (1047 bp), IV (1122
bp). Cluster IIb share 99% nucleotide identity to cofJ described in
this study, which we hypothesize to be CS8B. The cofJs from this
clade have 16 SNPs, resulting in 10 non-synonymous amino acid
substitutions relative to accession CEJ09709 of CS8B. The CS8-
JB primers described in this study amplify the cofJ of ESEI 111
(970 bp product) in addition to cofJ from Cluster IIb producing
a 968 bp product by in silico PCR, and the five variants of CS8
(Cluster Ia/b, IIa/b, IIIb) currently undetectable using the current
primers that amplify a region in the cofA gene.
It is of note that unlike CS8, which is occasionally coex-
pressed with CS6 (Shaheen et al. 2003), CS8B was the only de-
tected CF in the genome sequence of ETEC strain ESEI 111, novel
or otherwise. Although other strains of CS8 variants were not
available for in vitro testing, variants belonging to Cluster II can
be covered by primers described in this study. Therefore, includ-
ing CS8B primers that target cofJ and cofP alongside previously
described primers (Rodas et al. 2009) when screening for CFs is
recommended.
Considering that ETEC cause approximately 400 million diar-
rheal cases and almost 400 000 deaths per year in children un-
der 5 years of age extending our ability to detect and monitor
novel CFs found in low-/middle-income countries like Kenyawill
aid ETEC screening efforts and increase our ability to determine
how the diversity of these genes may influence host–pathogen
interactions. Importantly, this in turn may have future impli-
cations for vaccine development (Fleckenstein et al. 2010; Nada
et al. 2011; Begum et al. 2014).
Although cofJ of CS8B have been detected before, we be-
lieve this is the first whole CS8B operon report, a variant of
CS8. The annotated complete coding sequence reference for
the CS8B cof operon is LN651094 and respective gene sequences
have been deposited in the Genbank under accession numbers;
cofR- CEJ09697, cofS- CEJ09698, cofT- CEJ09699, cofA- CEJ09700,
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cofB- CEJ09701, cofC- CEJ09702, cofD- CEJ09703, cofE- CEJ09704,
cofF- CEJ09705, cofG- CEJ09706, cofH- CEJ09707, cofI- CEJ09708, cofJ-
CEJ09709 and cofP- CEJ09710.
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